BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

News Image - KIRO 7 News
External News

WA Pfizer vaccine trial participants share experiences for the first time

Watch video ➡
News The Seattle Times
External News

Front-line medical workers get first doses of coronavirus vaccine in Seattle

Read more ➡
News Image - KIRO 7 News
External News

Pfizer testing COVID-19 vaccine on kids and Moderna is next – but some parents are worried

Watch video ➡
News Image - Yahoo! Finance
External News

LRA's 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development

Read more ➡
News Medical Life Sciences
External News

Mild COVID-19 disease may trigger long-term immunity

Read more ➡
News Image - Puget Sound Business Journal
External News

Benaroya Research Institute president pulls back the curtain on Covid-19 study

Read more ➡
Press Release

Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason

Read More
News Main Image - JAMA Network
External News

Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses

Read more ➡
News Science in Seattle
External News

Science in Seattle: Targeting the Genetic Roots of Autoimmunity

News Main Image - Journal JAMA Pediatrics
Press Release

Early introduction of gluten may prevent celiac disease in children

Read More
News Pacific Lutheran University PLU
External News

Thu “Kim” Le interns with Benaroya Research Institute, doing cancer research from home

Read more ➡
News Image - Healthline
External News

‘Lost time and momentum’

News Main Image - Journal Science AAAS
Press Release

Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses

Read More
News Main Image - Journal Science AAAS
News

Geekwire: Researchers discover new avenue for fighting COVID-19, Ebola and other viral diseases

Read More
News Main Image - Journal Science Transl Med
Press Release

GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases

Read More